Home » Topics » Substance use and poisoning, BioWorld Science

Substance use and poisoning, BioWorld Science
RSS

Invion begins phase II INV-102 trial

July 26, 2013

Novel drug and drug target for the treatment of addictive disorders characterized

July 24, 2013

Pluristem's PLX cells tested for treatment of radiation poisoning

July 17, 2013

Novel kappa receptor antagonists disclosed by Research Triangle Institute

July 1, 2013

First patient dosed in phase III study of Zubsolv for new indication

June 19, 2013

Neumedicines receives BARDA award for HemaMax

June 11, 2013

Nippon Shinyaku launches Regtect in Japan

May 27, 2013

Neumedicines receives BARDA intent to exercise contract option on HemaMax

May 17, 2013

Biotie reports initiation of NIH-funded study of nepicastat in cocaine dependence

May 13, 2013

FDA issues complete response letter declining approval of Probuphine

May 3, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Fauci’s silence may put him in contempt of Congress
BioWorld
After repeatedly invoking the Fifth Amendment to every question asked during the July 29 hearing of the U.S. Senate Homeland Security Committee, Anthony Fauci,...